Why Idexx Laboratories Stock Surged by Almost 15% Today

Animal healthcare diagnostics specialist Idexx Laboratories' (NASDAQ: IDXX) stock was an unquestionably healthy investment on Monday. Market players flocked to the company's shares following the release of a fresh set of quarterly earnings. Idexx closed the day nearly 15% higher in value, crushing the 0.2% gain of the S&P 500 index. Idexx published its third-quarter figures well before market open that day. The company divulged that its revenue was almost $1.11 billion, up a sturdy 13% from the same period of 2024. Net income according to generally accepted accounting principles (GAAP) rose more sharply, growing by 18% to $274.6 million. On a non-GAAP (adjusted) per-share basis, net income rose 15% to $3.22.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool